homevideos Newsbusiness Newscompanies News

COVID vaccination for 12 18 yr olds: Awaiting NTAGI clearance, says Zydus

videos | Mar 25, 2022 5:23 PM IST

COVID vaccination for 12-18 yr olds: Awaiting NTAGI clearance, says Zydus

Mini

Zydus Lifesciences is waiting for the National Technical Advisory Group on Immunization’s (NTAGI) clearance for vaccines for 12-18-year-olds, Sharvil Patel, managing director, told CNBC-TV18.

Zydus Lifesciences is waiting for the National Technical Advisory Group on Immunization’s (NTAGI) clearance for vaccines for 12-18-year-olds, Sharvil Patel, managing director, told CNBC-TV18.

Recommended Articles

View All

In an interview to CNBC-TV18, he said, “Between the age group of 12 and 18, for which we have already completed our trial and submitted it and waiting for, we already have a Drugs Controller General of India (DCGI) approval but waiting for NTAGI clearance to a booster dose strategy that has been worked out where we have to change vaccines from the earlier vaccination to the next vaccine to potentially then the younger age group of 5-12 and also the export market.”
Talking about the DNA platform, Patel said, “The DNA platform vaccine is a new platform that has been created by the company for COVID. This vaccine platform has the potential to be developed for other viruses as well and we will continue to work on that.”
However, said Patel, Zydus is not at a scale of producing a large number of COVID-19 vaccine doses, but the peak production estimate is 1 crore doses per month.
For more details, watch the accompanying video
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng